U.S. Healthtech Stock News

Recent performance snapshot ACADIA Pharmaceuticals (ACAD) has been relatively stable over the past year, with a 1 year total return of 29.11%. It has also shown a modest negative move year to date and over the past month. The stock’s past 3 months return is close to flat, and its 3 year total return of 23.07% contrasts with a 5 year total return that remains negative. This highlights a mixed longer term picture for shareholders. See our latest analysis for ACADIA Pharmaceuticals. With the...

Diversified Healthcare Trust has reported its fourth-quarter and 2025 results, with full-year revenue holding around US$1.54 billion while the annual net loss narrowed to US$285.89 million and funds from operations for the quarter reached US$21.8 million, or US$0.09 per share. Beyond the headline earnings, DHC delivered 31.3% consolidated net operating income growth in 2025, completed over US$1.40 billion of capital markets activity including the sale of 69 properties, and entered 2026 with...

In recent days, Wells Fargo analyst Jason Kupferberg maintained a Sell rating on Paychex, while corporate insider Joseph Doody, a company director, bought 1,000 shares amid muted 8.7% annual revenue growth and rising expenses that reduced operating margins. This combination of cautious analyst coverage and increased insider buying highlights a tension between external skepticism and internal confidence in Paychex’s prospects. We’ll now examine how this mix of cautious analyst sentiment and...

In February 2026, The Sherwin-Williams Company’s board approved a higher regular quarterly dividend of US$0.80 per share, payable on March 13, 2026, while the company also faced a new California class action alleging multiple labor code violations over wages, breaks, and expense reimbursement. This combination of a long-running pattern of dividend increases and fresh legal challenges highlights the tension between shareholder payouts and potential labor-related liabilities. We’ll now examine...

Ionis Pharmaceuticals FY 2025 earnings snapshot Ionis Pharmaceuticals (IONS) closed FY 2025 with fourth quarter revenue of US$203 million and a basic EPS loss of US$1.41, alongside a trailing twelve month revenue base of US$944 million and a TTM basic EPS loss of US$2.38. Over the past year, quarterly revenue has moved between US$131.6 million and US$452.0 million, while basic EPS swung from a profit of US$0.78 in Q2 2025 to losses of US$0.93 in Q1 and US$0.80 in Q3. This sets up a results...

Nu Holdings Ltd. has released its full-year 2025 results, reporting net interest income of US$8.86 billion and net income of US$2.87 billion, with both basic and diluted earnings per share from continuing operations higher than the prior year. The earnings confirm that Nu Holdings is converting its expanding digital banking footprint into higher profitability, offering investors clearer visibility into how its business model scales across products and markets. Next, we’ll examine how this...

Calix (NYSE:CALX) is working with Cablelynx, the broadband arm of WEHCO Video, to deploy its SmartBiz service for small businesses and SmartTown for broader community Wi-Fi. The deployments are aimed at improving secure connectivity, customer engagement, and managed services for local enterprises and residents. This development highlights real world use of the Calix One platform beyond residential broadband, focusing on business transformation and community connectivity. For investors...

If you are wondering whether Papa John's International at around US$33.83 is a bargain or a value trap, you are not alone. This article is built to help you size up the stock in a clear, structured way. The share price has moved 3.0% over the last week, while returns sit at a 7.0% decline over 30 days, a 16.1% decline year to date and a 23.4% decline over the past year, extending a 56.0% decline over three years and a 54.7% decline over five years. Recent attention on Papa John's has focused...

If you are wondering whether Shake Shack, at around US$92 a share, is priced for perfection or still offers value, this article walks through what that current price might mean for investors. The stock is at US$92.13 after a 2.2% decline over the last 7 days, a 1.7% gain over 30 days, a 10.4% gain year to date, a 16.4% decline over 1 year, and a 19.1% decline over 5 years, with a 61.4% gain across 3 years. Recent headlines around Shake Shack have focused on the brand's ongoing expansion, new...

Tarsus Pharmaceuticals, Inc. reported full-year 2025 results on February 23, 2026, with revenue rising to US$451.36 million from US$182.95 million and its net loss narrowing to US$66.42 million, while also filing a US$141.73 million common stock shelf registration tied to an ESOP-related offering. The company highlighted XDEMVY as a breakout eye-care therapy, complemented by advancing pipeline programs and the appointment of long-time Allergan leader David E. I. Pyott to its Board,...

If you are wondering whether Albemarle's share price still offers value after a strong run, this article will walk through how the current price compares with different valuation checks. The stock last closed at US$195.87, with returns of 14.4% over 7 days, 3.2% over 30 days, 36.1% year to date, 157.9% over 1 year, negative 18.9% over 3 years, and 41.4% over 5 years. This provides a mixed picture of recent and longer term performance. These moves have arrived alongside ongoing attention on...

Why ESCO Technologies (ESE) is on investors’ radar today ESCO Technologies (ESE) has caught investor attention after a recent share price move, with the stock showing a 2.3% decline over the past day alongside gains over the past week and month. See our latest analysis for ESCO Technologies. That 2.3% one day pullback comes after a strong run, with a 30 day share price return of 25.8% and a year to date share price return of 41.2%, while total shareholder return stands at 72.3% over the past...

If you are wondering whether Extra Space Storage is reasonably priced at around US$146.87, or if the market is overlooking something in plain sight, this article is for you. The stock has returned 1.2% over the past 7 days, 4.8% over 30 days, 12.1% year to date, 2.2% over 3 years, 44.1% over 5 years, and is roughly flat over 1 year with a 0.1% decline. Taken together, this gives you a mixed picture of recent sentiment and long term holding outcomes. Recent headlines around Extra Space...

Harmony Biosciences Holdings recently reported Q4 2025 results showing net income of US$22.49 million and diluted EPS of US$0.38, alongside full-year 2025 net income of US$158.69 million and reiterated 2026 WAKIX net revenue guidance of US$1.00 billion to US$1.04 billion. At the same time, FDA approval extending WAKIX to treat cataplexy in pediatric narcolepsy patients and progress securing its intellectual property framework could be important for Harmony’s long-term WAKIX franchise and...

Dow stock overview after recent performance shift Dow (DOW) has drawn fresh attention after a recent stretch of mixed returns, including a 3.3% decline over the past day and a 4.9% decline over the past week, which contrasts with gains over the past month and over the past 3 months. See our latest analysis for Dow. With the share price at US$30.02, Dow’s recent pullback comes after a stronger stretch, including a 30 day share price return of 6.53% and a 90 day share price return of 25.55%...

Cisco, SharonAI Holdings and NVIDIA recently launched Australia’s first Cisco Secure AI Factory, a sovereign AI infrastructure platform powered by 1,024 NVIDIA Blackwell Ultra GPUs, Cisco UCS servers, Nexus Hyperfabric and VAST Data storage to keep all AI data and processing within the country. This AI-focused build-out, alongside Cisco’s expanded AI-enabled partnerships with firms such as HCLTech and TCS, reinforces its ambition to sit at the core of secure, large-scale enterprise AI...

What Lincoln National’s Recent Share Performance Tells You Lincoln National (LNC) has seen mixed returns recently, with the share price up about 1% over the past year but showing declines over the past month and past 3 months. That contrast between short term weakness and a slightly positive 1 year total return can prompt investors to look more closely at how the insurer’s business segments and recent financial results might be influencing sentiment. See our latest analysis for Lincoln...

If you are wondering whether Dover's current share price truly reflects its underlying worth, you are not alone. This article is designed to help you weigh what you are paying against what you are getting. Dover shares last closed at US$226.73, with returns of 9.2% over 30 days, 15.8% year to date and 16.0% over the past year, which may indicate that the market is reassessing its future prospects and risk profile. Recent coverage has focused on Dover's role in the broader capital goods space...

If you are wondering whether Robert Half's current share price reflects its real worth, you are not alone. This article focuses squarely on what the numbers say about value. The stock closed at US$23.58, with returns of a 9.0% decline over the past week, 16.8% decline over the past month, 13.8% decline year to date, 57.3% decline over 1 year, 66.6% decline over 3 years, and 63.6% decline over 5 years, which raises obvious questions about how the market is currently pricing the...

In recent weeks, analysis highlighted that Independent Bank Corp. (NASDAQ: INDB) met Minervini Trend Template criteria while reporting quarterly EPS growth of 40.5% year over year and revenue growth of 43.6%, underscoring strong recent earnings and sales momentum. Beyond the headline growth, the combination of robust operating results and a share price near 52-week highs points to growing investor attention on the bank’s execution and balance of technical and fundamental strength. We’ll...

Why Cathay General Bancorp Is On Investors’ Radar Cathay General Bancorp (CATY) has attracted fresh attention after recent share price moves, with a 2.7% gain over the past day and mixed shorter term returns across the week, month, and past 3 months. See our latest analysis for Cathay General Bancorp. The recent 1 day share price return of 2.7% sits within a steadier pattern, with a 30 day share price return of 5.2% and a year to date share price return of 8.0%. Meanwhile, the 1 year total...

If you are wondering whether Brinker International's current share price reflects its true worth, you are not alone. Many investors are asking the same question after a strong multi year run. The stock recently closed at US$144.90, with returns of an 8.5% decline over 7 days, a 7.9% decline over 30 days, a 4.4% decline year to date, a 9.5% decline over 1 year, a 271.0% gain over 3 years and a 103.1% gain over 5 years. These moves have come alongside ongoing attention on the restaurant sector...

China Yuchai International (CYD) has released its 2025 results, reporting sales of CN¥24,661.77 million and net income of CN¥537.39 million. The company noted heavier engine demand and ongoing investment in new energy technologies. See our latest analysis for China Yuchai International. Despite the latest earnings, the current share price of US$43.52 comes after a 9.31% 1 day share price decline and a 22.20% 7 day share price decline. However, the 90 day share price return of 23.22% alongside...

If you are wondering whether Dynatrace is starting to look interesting at today’s price, this article will walk through what the current share price might imply about its value. The stock is trading at US$35.14, with returns of a 3.5% decline over 7 days, 14.7% decline over 30 days, 17.0% decline year to date, 40.2% decline over 1 year, 16.7% decline over 3 years and 30.4% decline over 5 years. These moves may have shifted how some investors see its risk and return profile. Recent news...